EPISODE · Jul 12, 2023 · 33 MIN
Numinus with Tim Regan and Payton Nyquvest
from WTR Small-Cap Spotlight · host Water Tower Research LLC
Send us Fan MailWater Tower Research Head of Business Development Tim Regan and Numinus Founder, Chair, and CEO Payton Nyquvest discuss the improving landscape in psychedelics. Payton shares how he felt energized and encouraged following the recent MAPS Psychedelic Science conference in Denver. Numinus is partnering with MAPS on MDMA clinical trials and Payton provides an update on their progress and explains how once approved MDMA may be integrated into their existing clinical infrastructure. Finally, we cover the widespread application of psychedelics and how they can help improve a range of mental health conditions.
What this episode covers
Send us Fan Mail Water Tower Research Head of Business Development Tim Regan and Numinus Founder, Chair, and CEO Payton Nyquvest discuss the improving landscape in psychedelics. Payton shares how he felt energized and encouraged following the recent MAPS Psychedelic Science conference in Denver. Numinus is partnering with MAPS on MDMA clinical trials and Payton provides an update on their progress and explains how once approved MDMA may be integrated into their existing clinical infrastructur...
NOW PLAYING
Numinus with Tim Regan and Payton Nyquvest
No transcript for this episode yet
Similar Episodes
Jun 12, 2025 ·30m
Apr 22, 2025 ·32m
Apr 17, 2025 ·16m
Feb 27, 2025 ·0m
Dec 16, 2024 ·39m